Respiratory Syncytial Virus (RSV) is associated with lower respiratory tract infections resulting in approximately 34 million cases each year in children less than 5 years and responsible for an estimated 160,000 deaths per year worldwide. The disease and economic burden of RSV are poorly documented and private-public partnerships are required to use existing data and generate new data in order to increase the evidence pool on RSV-related infections, as well as raise awareness on the topic for decision-makers and the general community.
This session, taking place on Thursday, 19 November at 10.30 will provide a systemic and holistic overview of RSV, by presenting its risks factors, impact, and management in different settings of the health ecosystem.
We are pleased to have with us renowned speakers including Prof. Harish Nair, Chair of Paediatric Infectious Diseases and Global Health at the Centre for Global Health, Usher Institute, The University of Edinburgh. Representing the Spanish perspective we will have Dr Javier Diez-Domingo, MD, Head of the Vaccine Research Department, Centre of Public Health Research of Valencia-FISABIO and Juan José García García, MD, PhD, Head of the Pediatrics Department, Sant Joan de Deu Barcelona Children’s Hospital. Finally, representing the UK perspective we will have Dr. Simon Drysdale, Clinical Lecturer and honorary specialty registrar in paediatric infectious diseases at Oxford University and the Children’s Hospital, and Dr. Simon Nadel, Consultant in Paediatric Intensive Care at St Mary’s Hospital and Imperial College London.
